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Objective: The present work was designed to study the myocardial perfusion
and energy metabolism during retrograde cardioplegia performed with dif-
ferent methods, including deep coronary sinus cardioplegia, coronary sinus
orifice cardioplegia, and right atrial cardioplegia.
Methods: Isolated pig hearts were subjected to antegrade cardioplegia, right
atrial cardioplegia, deep coronary sinus cardioplegia, and coronary sinus ori-
fice cardioplegia in a random order. Cardioplegic distribution was assessed
by T1-weighted magnetic resonance imaging in 1 group of hearts (n = 8).
The flow dynamics of cardioplegia were assessed by T2*-weighted imaging
in a second group of hearts (n = 8).
Results: T1-weighted images revealed an apparent perfusion defect in the
posterior wall of the left ventricle, the posterior portion of the interventricu-
lar septum, and the right ventricular free wall during deep coronary sinus
cardioplegia. The perfusion defect observed in the first 2 regions with deep
coronary sinus cardioplegia resolved with coronary sinus orifice cardiople-
gia. Right atrial cardioplegia provided the most homogeneous perfusion to
all regions of the myocardium relative to the other 2 retrograde cardioplegia
modalities. T2*-weighted images showed that the 3 retrograde cardioplegia
modalities provided similar cardioplegic flow velocities. Localized phos-
phorus 31 spectroscopy showed that the levels of adenosine triphosphate and
phosphocreatine were significantly lower in the posterior wall (adenosine
triphosphate, 42.86% ± 5.91% of its initial value; phosphocreatine, 11.43%
± 11.3%) than the anterior wall (adenosine triphosphate, 89.19% ± 8.83%;
phosphocreatine, 59.54% ± 12.58%) of the left ventricle during 70 minutes
of normothermic deep coronary sinus cardioplegia.
Conclusions: Deep coronary sinus cardioplegia results in myocardial
ischemia in the posterior wall of the left ventricle and the posterior portion
of the interventricular septum, as well as in the right ventricular free wall.
Coronary sinus orifice cardioplegia improves cardioplegic distribution in
these regions. Relative to deep coronary sinus cardioplegia and coronary
sinus orifice cardioplegia, right atrial cardioplegia provides the most homo-
geneous perfusion.  (J Thorac Cardiovasc Surg 2000;120:544-51)
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R etrograde cardioplegia has been accepted as analternative technique for myocardial protection
during cardiac surgery in a variety of cardiac surgical
procedures, particularly in valve and coronary bypass
surgery.1-3 The rapid gain in its popularity is probably
due to the finding that nutritional flow of retrograde
cardioplegic solution is sufficient to sustain the reduced
energy demands of the arrested heart.4,5 In addition, use
of retrograde cardioplegia provides a less cluttered
operative field than does antegrade cardioplegia.
Inasmuch as the coronary venous system is not affect-
ed by atherosclerosis, retrograde cardioplegia may be
better than antegrade cardioplegia in protecting the
jeopardized myocardium supplied by occluded coro-
nary arteries.6-8
Retrograde cardioplegia can be carried out through
various means. Some surgeons deliver cardioplegic
solution through a retrograde catheter placed far into
the coronary sinus with a balloon fully inflated to
ensure proper wedging of the catheter in the coronary
lumen (we refer to this technique as deep coronary
sinus cardioplegia [DCSC]).7,9-11 Others prefer to
tighten up the orifice of the coronary sinus using a
purse-string suture with minimum balloon inflation
during retrograde cardioplegia (we named this method
coronary sinus orifice cardioplegia [CSOC]).12,13 The
right atrium has also been used as a site for delivering
cardioplegic solution (right atrial cardioplegia
[RAC]).14-16 The 3 modalities have all been used in car-
diac surgery. Each technique has its advantages and
disadvantages in terms of operation placement,
myocardial cooling efficacy, and the possibility of
complications. It has not been demonstrated whether
there are any significant differences between these
techniques in terms of myocardial perfusion.
The present study was to assess the effects of the 3
retrograde cardioplegia modalities on myocardial per-
fusion and energy metabolism under normothermic
conditions. Perfusion magnetic resonance imaging
(MRI) was used to assess distribution and flow dynam-
ics of cardioplegic solutions. Localized phosphorus 31
(31P) MRI spectroscopy was used to assess regional
myocardial energy metabolism during DCSC.
Methods
Isolated pig heart preparation. All animals received
humane care in compliance with the “Guide for the Care and
Use of Experimental Animals” formulated by the Canadian
Council on Animal Care, and the protocols used in this study
were approved by the Animal Care Committee of National
Research Council of Canada.
Standard procedures for the isolated heart preparation have
been previously described.5 The following is the outline of a
few key procedures used in this study. Domestic pigs weigh-
ing 45 to 50 kg were sedated with an intramuscular injection
of atropine (0.05 mg/kg body weight), diazepam (0.4 mg/kg
body weight), and ketamine (20 mg/kg body weight).
Anesthesia was maintained with 1.5% to 2.0% isoflurane in a
mixture of oxygen and medical air. A sternotomy was per-
formed, and the great arteries and veins were dissected and
clamped. Heparinized cold (~4°C) cardioplegic solution was
delivered into the aortic root to arrest the hearts. After
removal, the isolated hearts were mounted on a Langendorff
perfusion apparatus.
Perfusion medium. The isolated pig hearts were perfused
with a mixture of pig blood and modified Krebs-Henseleit solu-
tion in a 1:1 ratio, leading to an average hematocrit level of
13.1% ± 3.5%. Krebs-Henseleit solution contained the follow-
ing components: NaCl, 118 mmol/L; KCl, 16 mmol/L; MgCl2,
16 mmol/L; glucose, 11 mmol/L; NaHCO3, 25 mmol/L; CaCl2,
1.75 mmol/L; ethylenediaminetetraacetic acid, 0.5 mmol/L;
KH2PO4, 1.2 mmol/L; and bovine serum albumin, 0.5%. The
mixture was oxygenated with a 95% oxygen/5% carbon diox-
ide gas, and the pH of the mixture was maintained at 7.35 to
7.45. The final concentration of K+ and Mg++ in the mixture was
adjusted to 16 mmol/L to keep the heart arrested throughout the
protocol. There were no differences in composition of the car-
dioplegic solutions between groups.
Retrograde cardioplegia. In this study retrograde cardio-
plegia was performed with the use of a 15F retrograde can-
nula (DLP Inc, Grand Rapids, Mich) with a manually inflat-
ed balloon at the tip. The perfusion pressures for retrograde
and antegrade cardioplegia were controlled in the same pres-
sure ranges (30-40 mm Hg). This pressure range of antegrade
cardioplegia is sufficient to maintain normal myocardial
energy homeostasis and to prevent myocardial ischemia.5,17
Heart temperature was maintained at 36.5°C ± 0.5°C
throughout the protocol.
RAC was conducted by inserting a retrograde cannula into
the right atrium through the right atrial appendage and then
ligating both venae cavae and the pulmonary artery.
Retrograde cardioplegia through the coronary sinus was con-
ducted by means of 2 different modalities. One involved plac-
ing a retrograde cannula far into the coronary sinus with the
balloon fully inflated. This technique was termed DCSC.
With the second technique, retrograde cardioplegia was per-
formed through a retrograde cannula positioned approxi-
mately 1 cm into the coronary sinus. The orifice of the coro-
nary sinus was tightened by means of a purse-string suture.
The balloon was not inflated to avoid blocking the ostia of the
posterior interventricular vein and the posterior veins of the
left ventricle (LV). This retrograde cardioplegia method was
referred to as CSOC.
Group and protocols. The hearts in groups 1 (n = 8) and
2 (n = 8) were subjected to the same protocol, which consist-
ed of 10 minutes of antegrade cardioplegia, 10 minutes of
RAC, 10 minutes of DCSC, and 10 minutes of CSOC in ran-
dom order. In group 1, 3 mL of an extracellular MRI contrast
reagent (gadolinium-diethylenetriamine pentaacetic acid
[Gd-DTPA]; Berlex, Montreal, Canada) was injected as a
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bolus into the cardioplegia line during each period of the pro-
tocol. The distribution of the contrast reagent (representative
of cardioplegic distribution) was determined by using T1-
weighted MRI. Five milliliters of an intravascular MRI con-
trast reagent (Gd-DTPA-polylysine; Schering AG, Berlin,
Germany) was injected into the cardioplegia line during each
period of the protocol in group 2 hearts to assess cardioplegic
intracapillary flow velocity by using T2*-weighted MRI.
Both T1- and T2*-weighted images covered a 15 × 15–cm2
field of view with a 128 × 128 matrix, leading to a pixel size
of 1.17 × 1.17 mm2. During the intervals between each peri-
od of the protocol, the hearts in both groups were subjected to
approximately 2 minutes of antegrade perfusion to ensure a
complete washout of the contrast reagent injected previously
to preclude its potential interference with the subsequent MRI
assessment. Eight T1-weighted images were usually acquired
near the end of the 2-minute antegrade interval to determine
whether the contrast agent had been completely washed out.
Complete washout of contrast agent must be achieved before
starting the next retrograde perfusion.
To determine whether DCSC results in regional myocardial
ischemia, we subjected the hearts in group 3 (n = 6) to a proto-
col consisting of 10 minutes of antegrade cardioplegia, 70 min-
utes of DCSC, and 10 minutes of antegrade cardioplegia. The
temperature of the hearts was kept at 36.5°C ± 0.5°C. An MRI
surface coil was placed on the anterior and posterior walls of the
LV, respectively, to monitor the changes in energy metabolites
in the 2 regions of the myocardium on a continuous basis. Each
31P spectrum was acquired over a 4-minute period.
MRI and spectroscopy were performed in a 7-T, 40-cm
horizontal bore magnet equipped with a Biospec spectrome-
ter (Bruker Inc, Karlsruhe, Germany).
Image processing and data analysis. Image data were
processed by using EvIdent (a 2D/3D image analysis software;
Institute for Biodiagnostics, NRC, Winnipeg, Canada). Because
Gd-DTPA increases the signal intensity in the myocardium,
bright areas in T1-weighted images indicate the regions of per-
fused myocardium, and dark areas reveal nonperfused
myocardium. The effect of the retrograde cardioplegia modali-
ties on flow dynamics was assessed by measuring the mean
transit time of Gd-DTPA-polylysine. This parameter implies
average time required for the contrast reagent to travel along
blood flow from the injection site to the imaging slice.
Statistical analyses were performed by STATISTICA soft-
ware (Statsoft Inc, Tulsa, Okla). All numeric results are
expressed as means ± SE. The comparison of phosphorus
metabolites (adenosine triphosphate, phosphocreatine, and
inorganic phosphate) observed in the anterior and posterior
walls of the LV during DCSC were carried out by 1-way
analysis of variance with repeated measures. The same test
was used to compare the mean transit times obtained with the
4 different perfusion modalities.
Results
Representative T1-weighted images obtained from
group 1 during each period of the protocol are shown in
Fig 1. All regions of the myocardium brightened equal-
ly during antegrade perfusion (Fig 1, left top panel),
indicating that antegrade cardioplegia, even at a rela-
tively low perfusion pressure, provided homogeneous
distribution of cardioplegic solution to all regions of
the myocardium. This perfusion characteristic of ante-
grade cardioplegia was observed in all hearts (8/8).
When the hearts were subjected to DCSC, no contrast
agent was detected in the posterior portion of the inter-
ventricular septum, the posterior wall of the LV, or in
the right ventricular free wall (Fig 1, left bottom panel).
Although the relative sizes of the nonperfused regions
varied from heart to heart, all hearts showed similar
perfusion defects in these regions during DCSC. Even
within the DCSC-supplied regions (the anterior and lat-
eral walls of the LV), the distribution of Gd-DTPA was
heterogeneous, suggesting that patches of myocardium
could become ischemic. During CSOC, the posterior
portion of the interventricular septum and the posterior
wall of the LV were as bright as the anterior and later-
al walls of the LV, suggesting that CSOC improved
myocardial perfusion in these regions relative to DCSC
(Fig 1, right bottom panel). The size of the unperfused
region in the right ventricular wall was also reduced.
Two hearts (2/8) did not show any apparent perfusion
defect in the right ventricular wall. The images
obtained during RAC showed uniform cardioplegic
distribution in both ventricular free wall and the inter-
ventricular septum (Fig 1, top right panel).
Under similar perfusion pressure, the cardioplegia
flow rate of RAC (101 ± 59 mL/min) was significantly
higher than those obtained with DCSC (42.6 ± 11.6
mL/min, P = .01) and CSOC (52.4 ± 20.5 mL/min, P =
.02). The difference in cardioplegia flow obtained dur-
ing DCSC and CSOC was not statistically significant
(P = .69).
T2*-weighted images showed that the mean transit
times of Gd-DTPA-polylysine were significantly 
(P = .001) longer with retrograde perfusion (608 ± 64
seconds) than with antegrade perfusion (54.8 ± 4.4 sec-
onds). This approximately 10 times longer mean tran-
sit time indicates that the flow velocity of retrograde
caridoplegia was about 10 times slower than that of
antegrade cardioplegia. If the vascular volumes were
comparable under the conditions of antegrade and ret-
rograde cardioplegia, this difference in mean transit
time could suggest that the nutritional flow of retro-
grade cardioplegia was approximately one tenth of that
obtained with antegrade cardioplegia. In addition,
among the 3 retrograde cardioplegia modalities, mean
transit time was not significantly different (RAC, 585 ±
62 seconds; DCSC, 621 ± 59 seconds; CSOC, 620 ± 66
546 Tian et al The Journal of Thoracic and
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seconds), suggesting that they provided similar nutrient
flow per unit of tissue in the perfused areas.
Comparisons of the myocardial energy metabolites
measured at the anterior and posterior walls of the LV
during DCSC are shown in Figs 2, 3, and 4. During 70
minutes of DCSC, the posterior wall of the LV showed
a rapid decrease in phosphocreatine level and an
increase in inorganic phosphate level (Figs 2 and 3). At
the end of 70 minutes of DCSC, the phosphocreatine
level was significantly (P = .02) lower in the posterior
(11.4% ± 11.3% of its control level) than in the anteri-
or (59.5% ± 12.5% of its control level) wall of the LV
(Fig 2). After the switch to antegrade cardioplegia
(reperfusion), the anterior myocardium showed a com-
plete recovery of phosphocreatine (105% ± 25% of its
control value), whereas the recovery of phosphocre-
atine level in the posterior wall of the LV was very lim-
ited (41.7% ± 16.6% of its control value, Fig 2). In
synchrony with the changes in phosphocreatine, the
inorganic phosphate level was significantly higher in
the posterior (702% ± 153% of its initial value) than
the anterior wall (267% ± 16% of its initial value) of
the LV at the end of 70 minutes of DCSC (Fig 3).
Intracellular pH in the posterior wall of the LV (6.3 ±
0.05 pH unit) was also significantly (P = .02) lower
than that of the anterior wall of the LV (6.7 ± 0.1 pH
unit) at the end of DCSC. Furthermore, the posterior
wall of the LV showed a significantly (P = .001) lower
level of adenosine triphosphate (42.8% ± 5.9% of its
initial value) at the end of 70 minutes of DCSC than
that (89.1% ± 8.8%) observed in the anterior wall of
the LV (Fig 4). Switching to antegrade cardioplegia
Fig 1. Representative T1-weighted images obtained during antegrade cardioplegia (AC), right atrial cardioplegia
(RAC), deep coronary sinus cardioplegia (DCSC), and coronary sinus orifice cardioplegia (CSOC). LV, Left ventri-
cle; RV, right ventricle.
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(reperfusion) did not lead to any recovery in the
adenosine triphosphate level in the posterior part of the
LV wall (Fig 4).
Discussion
Uniform distribution of cardioplegic solution to all
regions of the myocardium is a prerequisite for achiev-
ing optimal myocardial protection. Coronary arterial
disease, aortic stenosis, or aortic insufficiency may
compromise the delivery of cardioplegic solution, lead-
ing to regional myocardial ischemic injury. It has been
demonstrated that the coronary venous system is not
affected by atherosclerosis and that the nutritional flow
of retrograde perfusion may be sufficient to sustain
myocardial energy demands of the arrested heart.4-6,18
This fact, along with the absence of instruments in the
operative field, has made retrograde cardioplegia an
alternative for myocardial protection. As mentioned
above, retrograde cardioplegia can be administered in
various modalities. It is therefore important to deter-
mine whether there is any significant difference among
these techniques in terms of cardioplegic distribution
Fig 2. The changes in phosphocreatine (PCr) levels in the anterior and posterior walls of the LV observed during
70 minutes of normothermic DCSC. Asterisks indicate a significant difference.
Fig 3. Changes in inorganic phosphate (Pi) levels in the anterior and posterior walls of the LV during DCSC.
Asterisks indicate a significant difference.
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and efficacy of myocardial protection. The present
study was designed to evaluate the efficacy of the 3 ret-
rograde delivery models by using MRI and spec-
troscopy.
The coronary veins may connect each other through
superficial venous anastomoses and intramural venous
networks.19-21 As a consequence of the presence of the
numerous venous anastomoses, the delivery of cardio-
plegic solution through some cardiac veins may result
in the irrigation of other cardiac veins through these
interconnecting vessels. However, we found in this
study that when the ostia of the posterior interventricu-
lar vein and the posterior veins of the LV were blocked
by the retrograde balloon (during DCSC), apparent per-
fusion defects were noted in the regions of myocardium
supported by the veins. The localized 31P MRI spectra
obtained during DCSC also demonstrated severe
ischemic changes in the posterior walls of the LV.
Tightening the orifice of the coronary sinus by means
of a purse-string suture may help open the coronary
veins that directly drain into the lumen of the coronary
sinus. We believe that this is the mechanism underlying
the improved perfusion observed in the posterior por-
tion of the interventricular septum and the posterior
wall of the LV during CSOC. Our results suggest that
DCSC does not provide adequate cardioplegic perfu-
sion to the posterior wall of the LV, the posterior por-
tion of the interventricular septum, or the right ventric-
ular free wall. Keeping the coronary venous ostia open
during retrograde cardioplegia is helpful, but not ideal,
for achieving homogeneous myocardial perfusion in
these regions. Our results also suggest that the superfi-
cial venous anastomoses and the intramural venous
networks may not be sufficient to irrigate the adjacent
coronary veins adequately. This apparent failure of the
venous anastomoses to provide adequate myocardial
perfusion in adjacent regions may be related to the spo-
radic valves present in the coronary veins.20,22 On the
other hand, it must also be mentioned that the develop-
ment of the venous collateral flow may be significant-
ly different between pigs and human subjects. It is
expected that venous anastomoses in elderly patients
may be much more developed than those in the young
healthy pigs used in this study. It has been demonstrat-
ed that coronary arterial disease stimulates the devel-
opment of the venous anastomoses.6 Therefore, it is
possible that the actual distribution of retrograde car-
dioplegic solution with DCSC in diseased human
hearts may be better than that observed in this study.
Therefore, extrapolating the data of this study to clini-
cal situations must be done with caution. In addition, it
has been demonstrated that the degree of superficial
venous anastomoses may vary significantly from heart
to heart. Because myocardial protection during cardiac
arrest is highly dependent on the homogeneity of car-
dioplegic distribution, efficacy of retrograde cardiople-
gia, in particular for the protection of the right ventri-
cle, may vary between individual hearts.
During RAC, all cardiac veins were adequately per-
fused, resulting in no apparent perfusion defect, even in
Fig 4.  Changes in the levels of adenosine triphosphate (ATP) in the anterior and posterior walls of the LV during
70 minutes of normothermic DCSC. Asterisks indicate a significant difference.
the right ventricular free wall. The potential adverse
effect of the sustained elevation of intraventricular pres-
sure during RAC remains to be determined. In addition,
it has been demonstrated that the thebesian vessels, a
continuation of the intramuscular venous plexuses chan-
neling directly to the ventricular chambers, drain approx-
imately 45% of venous blood of the myocardium.21,23-24
Under physiologic conditions, thebesian veins play an
important role in coronary venous drainage during the
systolic phase of a cardiac cycle.18 During retrograde
perfusion, thebesian vessels may divert a large portion of
retrograde solution delivered through the coronary sinus
from reaching the intramuscular venous plexus and the
capillaries.18 As a consequence of the heterogeneous dis-
tribution of the open and closed thebesian vessels, retro-
grade cardioplegia cannot provide homogeneous perfu-
sion.21 It is consistent with our observations in
T1-weighted images that some areas of the myocardium
in the anterior and lateral walls of the LV were not per-
fused during DCSC and CSOC. The elevated right ven-
tricular pressure during RAC may help nourish the
myocardium by delivering cardioplegic solution through
the thebesian vessels. This may be one of the reasons
underlying the improved distribution of retrograde car-
dioplegia with RAC relative to that observed with DCSC
and CSOC.
The results of the present study do not necessarily
suggest that CSOC and RAC are superior to DCSC
because cardioplegic distribution is not the only factor
determining the efficacy of myocardial protection.
Surgical occlusion of the coronary sinus orifice during
retrograde cardioplegia may be associated with some
unwanted effects. Additionally, it is not clear whether
prolonged right ventricular distension will damage
myocardium in the interventricular septum and the
right ventricular wall. Therefore, it must be with cau-
tion that we extrapolate the results of the present study
to clinical situations.
In summary, DCSC does not deliver cardioplegic
solution to the posterior portion of the interventricular
septum, the posterior wall of the LV, or the right ven-
tricular free wall, resulting in severe ischemic changes
in these regions. CSOC improves myocardial perfusion
in the posterior portion of the interventricular septum
and the posterior wall of the LV. RAC delivers cardio-
plegic solution to all regions of the myocardium.
Moreover, with retrograde cardioplegia alone, flow to
various regions of the myocardium may vary signifi-
cantly from one region to another, suggesting that ret-
rograde cardioplegia should be combined with ante-
grade cardioplegia to achieve adequate myocardial
protection.
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